Hansoh Pharma stock gains 3.67 percent as pharma shares rally

Published on 09/23/2026 at 03:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hansoh Pharma stock rose 3.67 percent on September 22, 2026, amid a broad Hong Kong pharmaceutical rally. The shares traded at HKD 35.64.

Hansoh Pharma, KYG4232C1087, Illustration mit AI erstellt.

Hansoh Pharmaceutical Group Company Limited (KYG4232C1087) gained 3.67 percent on September 22, 2026, as Hansoh Pharma shares traded at HKD 35.64 on the Hong Kong Stock Exchange. The move came during a broader pharmaceutical-sector advance reported by Futunn on September 22, 2026.

Pharma rally lifts the shares

The stock opened at HKD 34.02 and reached an intraday high of HKD 35.78 on September 22, 2026, according to the quoted Hong Kong market data. Hansoh Pharma's gain was smaller than the 13.75 percent increase for Jingfang Pharma-B and the 8.23 percent rise for Sino Biopharm reported in the same market session, giving investors a concrete measure of the sector's breadth.

Hansoh Pharma closed HKD 1.34 above the previous close of HKD 34.30 on September 22, 2026. Trading volume reached 11,894,635 shares, while the 52-week range stood at HKD 28.06 to HKD 44.22, leaving the closing price HKD 8.58 below the reported high.

Obesity drug remains a business catalyst

The company also has an established connection to the weight-loss drug market. A September 22, 2026 report carried by KSL said Merck signed a licensing deal worth up to USD 2 billion in 2024 for Hansoh Pharma's experimental oral obesity treatment. The agreement links Hansoh to a market dominated by Novo Nordisk and Eli Lilly, but the reported value is a potential deal ceiling rather than current revenue.

That distinction matters for interpreting the September 22 share move. The available market report quantified a 3.67 percent Hansoh gain and identified simultaneous advances across several pharmaceutical names, while the licensing figure describes a 2024 agreement and therefore should not be treated as a September 2026 earnings figure.

Stock remains below yearly high

Hansoh Pharma's market capitalization was HKD 215.599 billion on the Yahoo Finance snapshot dated September 22, 2026. The combination of a HKD 35.64 close, a HKD 44.22 52-week high and 11,894,635 shares traded provides the clearest dated market picture for the stock.

Hansoh Pharma closed at HKD 35.64 on the Hong Kong Stock Exchange on September 22, 2026, after rising 3.67 percent from the prior close of HKD 34.30. The price remained HKD 8.58 below the 52-week high of HKD 44.22.